Physician profile
Carolina Hernandez
NPI 1073559969
$608.16
in general payments reported to CMS, 2019-2025
11 companies · $127 in 2025
The $127 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $301 · 2020: $11.32 · 2022: $59.21 · 2023: $65.87 · 2024: $43.98 · 2025: $127.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $237.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $237.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $144.62 | 2019-2025 | |
| Novo Nordisk INC | $90.90 | 2019-2025 | Ozempic, Rybelsus |
| Amgen INC. | $77.86 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $72.66 | 2019 | |
| Exact Sciences Corporation | $63.60 | 2023-2025 | Cologuard Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $57.04 | 2025 | |
| Xeris Pharmaceuticals, INC. | $51.19 | 2023-2024 | Gvoke Hypopen |
| Allergan, INC. | $14.83 | 2019 | |
| Lilly USA, LLC | $12.75 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $11.39 | 2019 | |
| Merck Sharp & Dohme LLC | $11.32 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carolina Hernandez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.